Christina Eadicicco
Psychiatric/Mental Health · Sicklerville, NJNPI 1093478067
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 257 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,710, 7.3 times the $235 reported in 2022. Among psychiatric/mental health clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 257 payments — averaging $16.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$753
- AbbVie$679
- Vanda Pharmaceuticals Inc.$338
- Neurocrine Biosciences, Inc.$312
- Lundbeck LLC$249
- Axsome Therapeutics, Inc.$217
- plus $2K from 19 others
What the payments were for
- Food & beverage$4,12598%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 47 | $753 |
| AbbVie | 44 | $679 |
| Vanda Pharmaceuticals Inc. | 21 | $338 |
| Neurocrine Biosciences, Inc. | 19 | $312 |
| Lundbeck LLC | 15 | $249 |
| Axsome Therapeutics, Inc. | 14 | $217 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $213 |
| Corium, LLC | 15 | $186 |
| Teva Pharmaceuticals USA, Inc. | 6 | $183 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $151 |
| Tris Pharma Inc | 8 | $128 |
| Collegium Pharmaceutical, Inc. | 7 | $126 |
| Alkermes, Inc. | 8 | $123 |
| Neos Therapeutics, LP | 6 | $103 |
| Johnson & Johnson | 5 | $98 |
| E.r. Squibb & Sons, L.L.C. | 5 | $95 |
| Ironshore Pharmaceuticals Inc. | 4 | $60 |
| Noven Therapeutics, LLC | 3 | $48 |
| Almatica Pharma LLC | 3 | $45 |
| Idorsia Pharmaceuticals US Inc | 2 | $27 |
| Livanova USA, Inc. | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Sage Therapeutics, LLC | 1 | $17 |
| Bausch Health US, LLC | 1 | $16 |
| OWP Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$125
How this compares
$4,225 in reported general payments places this provider in the 90th percentile of 1,212 psychiatric/mental health providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 22 | $584 |
| Duloxetine Hcl | 18 | $348 |
| Fluoxetine Hcl | 16 | $344 |
| Hydroxyzine Pamoate | 11 | $267 |
| Clonazepam | 25 | $244 |
| Buspirone Hcl | 13 | $127 |
| Bupropion XlBupropion Hcl | 12 | $123 |
| Gabapentin | 12 | $104 |
| Alprazolam | 15 | $39 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Sicklerville
- Ubong UdofiaMarlton$407K
- Anthony DimuraRed Bank$130K
- Amy PinsenNewton$111K
- Aaron SpectorMarlton$100K
- Fiorella ParadisiSparta$84K
- Diane BurtBridgeton$81K
- Alta ManessHackensack$75K
- Laura LeahySewell$41K
- Linda WinfulMontclair$40K
- Marisa SavicOradel$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.